Days Inventory is also known as Days Sales of Inventory (DSI). Incyte's Average Total Inventories for the
three
months ended in Sep. 2024 was $86 Mil. Incyte's Cost of Goods Sold for the
three
months ended in Sep. 2024 was $86 Mil.
Hence, Incyte's Days Inventory for the
three
months ended in Sep. 2024 was 90.80.
The historical rank and industry rank for Incyte's Days Inventory or its related term are showing as below:
INCY'
s Days Inventory Range Over the Past 10 Years
Min: 14.47 Med: 34.01 Max: 88.32
Current: 88.32
During the past 13 years, Incyte's highest Days Inventory was 88.32. The lowest was 14.47. And the median was 34.01.
INCY's Days Inventory is ranked better than 77.76% of 643
companies
in the Biotechnology industry
Industry Median: 188.02
vs INCY: 88.32
Incyte's Days Inventory
increased
from Sep. 2023 (70.71) to Sep. 2024 (90.80).
It might indicate that Incyte's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Incyte's Inventory Turnover for the
three
months ended in Sep. 2024 was 1.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Incyte's Inventory-to-Revenue for the
three
months ended in Sep. 2024 was 0.08.
Incyte Days Inventory Historical Data
The historical data trend for Incyte's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Incyte's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Incyte's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Incyte's Days Inventory distribution charts can be found below:
* The bar in red indicates where Incyte's Days Inventory falls into.
Incyte Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Incyte's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Incyte (NAS:INCY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Incyte's Inventory Turnover for the
three
months ended in Sep. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Incyte's Inventory to Revenue for the
three
months ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Incyte Days Inventory Related Terms
Thank you for viewing the detailed overview of Incyte's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INCY has been successfully added to your 